0001209191-20-056084.txt : 20201028 0001209191-20-056084.hdr.sgml : 20201028 20201028162336 ACCESSION NUMBER: 0001209191-20-056084 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20201027 FILED AS OF DATE: 20201028 DATE AS OF CHANGE: 20201028 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Arnold James Robert Jr. CENTRAL INDEX KEY: 0001306988 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12537 FILM NUMBER: 201268957 MAIL ADDRESS: STREET 1: 18111 VON KARMAN AVE, SUITE 800 CITY: IRVINE STATE: CA ZIP: 92612 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NEXTGEN HEALTHCARE, INC. CENTRAL INDEX KEY: 0000708818 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER INTEGRATED SYSTEMS DESIGN [7373] IRS NUMBER: 952888568 STATE OF INCORPORATION: CA FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 18111 VON KARMAN AVENUE STREET 2: SUITE 800 CITY: IRVINE STATE: CA ZIP: 92612 BUSINESS PHONE: 949-255-2600 MAIL ADDRESS: STREET 1: 18111 VON KARMAN AVENUE STREET 2: SUITE 800 CITY: IRVINE STATE: CA ZIP: 92612 FORMER COMPANY: FORMER CONFORMED NAME: QUALITY SYSTEMS, INC DATE OF NAME CHANGE: 20180823 FORMER COMPANY: FORMER CONFORMED NAME: NEXTGEN HEALTHCARE, INC DATE OF NAME CHANGE: 20180823 FORMER COMPANY: FORMER CONFORMED NAME: QUALITY SYSTEMS, INC DATE OF NAME CHANGE: 20100804 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-10-27 0 0000708818 NEXTGEN HEALTHCARE, INC. NXGN 0001306988 Arnold James Robert Jr. 18111 VON KARMAN AVENUE SUITE 800 IRVINE CA 92612 0 1 0 0 Chief Financial Officer Common Stock 2020-10-27 4 A 0 60000 0.00 A 390730 D Performance Stock Units 2020-10-27 4 A 0 90000 0.00 A Common Stock 90000 185203 D The shares of restricted stock vest over three years from the date of grant in annual increments (i.e., 1/3 vest on the first anniversary of the date of grant, 1/3 vest on the second anniversary of the date of grant, and 1/3 vest on the third anniversary of the date of grant), subject to continued service through each vesting date. The performance stock unit awards vest only in the event certain performance goals are achieved and there is continuous service through the date the goals are certified. Approximately 80% of the performance stock units are tied to the Company's fiscal year 2022 revenue goal and 20% are tied to the Company's fiscal year 2023 revenue goal. Performance stock unit awards funded for fiscal year 2022 and fiscal year 2023 revenue performance will be modified for cumulative 3-year total shareholder return ("TSR") on the three-year grant date anniversary, which is also the cliff vest date. The number of shares to be issued may vary between 8.5% and 199.5% of the number of target performance stock units depending on performance, and no such shares will be issued if threshold performance is not achieved. Jeffrey D. Linton, Attorney-in-Fact for James R. Arnold, Jr. 2020-10-28 EX-24 2 attachment1.htm EX-24 DOCUMENT



POWER OF ATTORNEY
       Know all by these presents, that the undersigned hereby constitutes and
appoints the individuals named on Schedule A attached hereto and as may be
amended from time to time, or any of them signing singly, with full power of
substitution, as the undersigned's true and lawful attorney-in-fact to:
    1.	prepare, execute in the undersigned's name and on the undersigned's
behalf, and submit to the U.S. Securities and Exchange Commission (the "SEC") a
Form ID, including amendments thereto, and any other documents necessary or
appropriate to obtain codes and passwords enabling the undersigned to make
electronic filings with the SEC of reports required by Section 16(a) of the
Securities Exchange Act of 1934, as amended (the "Act"), Rule 13d-1 of the Act,
or any other  rule or regulation of the SEC;
    2.	execute for and on behalf of the undersigned, in the undersigned's
capacity as an officer, director and/or stockholder of NextGen Healthcare, Inc.,
a California Corporation (the "Company"), Forms 3, 4 and 5 in accordance with
Section 16(a) of the Act and the rules thereunder, Schedules 13D and 13G in
accordance with Rule 13d-1 of the Act, and any other forms or reports the
undersigned's may be required to file in connection with the undersigned's
ownership, acquisition or disposition of securities of the Company;
    3.	do and perform any and all acts for and on behalf of the undersigned's
which may be necessary or desirable to (i) complete and execute any such Form 3,
Form 4, Form 5, Schedule 13D, Schedule 13G or other forms or reports the
undersigned's may be required to file in connection with the undersigned's
ownership, acquisition or disposition of securities of the Company, (ii)
complete and execute any amendment or amendments thereto, and (iii) timely file
such forms or reports with the SEC and any stock exchange or similar authority;
and
    4.	take any other action of any type whatsoever in connection with the
foregoing which, in the opinion of such attorney-in-fact, may be of benefit to,
in the best interest of, or legally required by, the undersigned, it being
understood that the documents executed by such attorney-in-fact on behalf of the
undersigned pursuant to this Power of Attorney shall be in such form and shall
contain such terms and conditions as such attorney-in-fact may approve in such
attorney-in-fact's discretion.
       The undersigned hereby grants to each such attorney-in-fact full power
and authority to do and perform any and every act and thing whatsoever
requisite, necessary, or proper to be done in the exercise of any of the rights
and powers herein granted, as fully to all intents and purposes as the
undersigned might or could do if personally present, with full power of
substitution or revocation, hereby ratifying and confirming all that such
attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall
lawfully do or cause to be done by virtue of this Power of Attorney and the
rights and powers herein granted. The undersigned acknowledges that the
foregoing attorneys-in-fact, in serving in such capacity at the request of the
undersigned, are not assuming, nor is the Company assuming, any of the
undersigned's responsibilities to comply with Section 16 of the Act, Rule 13d-1
of the Act, or any other rule or regulation of the SEC.
       This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file reports required by the Act with
respect to the undersigned's holdings of and transactions in securities issued
by the Company, unless earlier revoked by the undersigned in a signed writing
delivered to the foregoing attorneys-in-fact and the Company.
       IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to
be executed as of
October 23, 2018.
____________________________________________
James R. Arnold



Schedule A

1. Jeffrey D. Linton
2. John R. Frantz
3. David Ahmadzai